ASHLYN MOREHOUSE: Open Payments
NPI 1962126128 · JOHNSON CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,260 in 96 payments from 12 companies in 2025. Trend: 2023 $177 · 2024 $921 · 2025 $1,260
Food & beverage: $1,260
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $334 |
| Vanda Pharmaceuticals Inc. | 15 | $274 |
| Braeburn Inc. | 6 | $99 |
| Gilead Sciences, Inc. | 4 | $90 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $83 |
| Otsuka America Pharmaceutical, Inc. | 4 | $82 |
| AstraZeneca Pharmaceuticals LP | 4 | $79 |
| Novo Nordisk Inc | 4 | $71 |
| Axsome Therapeutics, Inc. | 3 | $53 |
| Neurocrine BioSciences, Inc. | 2 | $35 |
Products named: VRAYLAR, FANAPT, HETLIOZ, BRIXADI, MAVYRET, CAPLYTA, REXULTI, Auvelity.
Industry payments across TN — which companies pay providers there.
